β-Amyrone

β-Amyrone (β-Amyron) is a triterpene compound which has anti-inflammatory activity through inhibiting the expression of COX-2 . β-Amyrone has antifungal activity , as well as antiviral activity against Chikungunya virus. β-Amyrone also inhibits α-glucosidase and acetylcholinesterase ( AChE ) activity. β-Amyrone can be used in the research of disease like inflammation, infection , and obesity In Vitro β-Amyrone (1.25-10 μg/mL, 24 h) inhibits on NO ∙ production in LPS-stimulated J774 cells, with an IC 50 value of 4.61 μg/mL, and has no obvious effect on cell viability. β-Amyrone (10 μg/mL, 24 h) inhibits IL-6, IL-10 levels, and COX-2 expression in LPS-stimulated J774 cells. β-Amyrone (0-235 μM, 7days) has antiviral activity in Vero cells against Chikungunya virus (CHIKV), with EC 50 value of 86 uM. β-Amyrone inhibits α-glucosidase, acetylcholinesterase (AChE) and fungal activity with IC 50 values of 25 μM, 23 μM and 8 μg/mL, respectively . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: LPS (1 μg/mL)-stimulated J774 cells Concentration: 2.5, 5, 10 μg/mL Incubation Time: 24 h Result: Inhibited COX-2 expression in a concentration-dependent manner (approximately 90% reduction at 5 or 10 μg/ mL). In Vivo β-Amyrone (local administration on ear, 0.1-0.6 mg/kg, a single dose) inhibits ear edema formation in phenol-induced edema mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Ear phenol-induced edema in Balb C mice Dosage: 0.1, 0.3, 0.6 mg/kg, a single dose Administration: Local administration (20

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet